A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE

Radiation Oncology Residency Program

Radiation Oncology Residency Program
The City of Hope Radiation Oncology Residency Program is a four-year Accreditation Council for Graduate Medical Education (ACGME) accredited program which begins in the PGY-2 year. The overall goal of the program is to train physicians to be outstanding radiation oncologists and to provide graduates with a solid foundation in translational and clinical research. The program emphasizes preparation for careers in academic radiation oncology. The selection process gives preference to those applicants who show an aptitude for academic medicine and with an interest in teaching, research and the application of cutting-edge translational technologies to cancer care.

Training is provided in clinical radiation oncology, treatment planning, radiation physics, and radiobiology, equipping graduates to provide comprehensive patient care as practicing radiation oncologists either in academia or the private practice setting. Residents actively participate in the management of a diverse variety of patients, with progressively increasing responsibilities during later phases of the Program. The attending physicians and the resident physicians work as a team, with the resident assuming primary care responsibilities for patients under the attending’s supervision. The resident-attending teams evaluate and counsel new patients and provide treatment which includes radiotherapy simulation, treatment planning, and administration of irradiation. The resident physician follows the patient throughout treatment with attending supervision and subsequently in post-radiotherapy follow-up clinics.

Please refer to Resident Handbook for complete outline of Program Year Objectives.

The total complement of residents is four, with one resident currently being accepted per year into the program. The program participates in the National and Resident Matching Program, with applications processed through the Electronic Residency Application Service (ERAS) common application program. (Refer to Application Process for more information)

City of Hope continues to be on the forefront of the latest treatment technology and clinical research, providing residents with a rich and comprehensive training environment. As an NCI designated comprehensive cancer center and charter member of the NCCN, City of Hope provides an excellent environment for residency education. A major and extensive renovation is underway that will increase the clinical area to 29,000 square feet with 4 treatment vaults, 3 imaging suites, a new clinic area and expansion of treatment planning and physics work space. Two Tomotherapy units, a Varian Trilogy and Varian IX will be installed. Multimodality functional tumor imaging will be a key part of the new center which will house MRI, PET/CT and CT units dedicated to treatment planning and treatment response assessment. In addition to these resources, radiation biology labs occupying a total of 4-5000 square feet currently house the labs of 4 NCI funded basic lab scientists. Finally an additional 8000 square feet is dedicated to an established radioimmunotherapy program with basic science laboratories and a radiopharmacy for the labeling of preclinical and clinical radiopharmaceuticals for tumor imaging and targeted tumor therapy.

Formal lectures cover radiation biology, physics, and clinical radiation oncology. clinical trial design, biostatistics, imaging (PET, SPECT, MRI,etc.), medical oncology and pediatric oncology. Multidisciplinary training will be emphasized. City of Hope has established fellowship programs in medical oncology, hematologic oncology, pathology, surgery, and urology. Ample interaction occurs through clinical conferences and tumor boards. Electives will be available with the other oncologic specialties.

Each resident will also be required to do an 8-12 month research rotation. He or she will select a lab or clinical research project to pursue, with the goal of publishing at least 2 manuscripts in peer-reviewed journals.

In accordance with the American Board of Radiology (ABR) for board eligibility, City of Hope requires successful completion of a clinical PGY1 year in the United States prior to commencing its four-year Radiation Oncology Residency Program.
 
 
Using leading edge technology, the Department of Radiation Oncology offers specialized services in external beam radiation therapy, radioactive seed implantation for prostate cancer, stereotactic radiosurgery and image guided intensity modulated radiation therapy. We also offer novel approaches to cancer therapy, such as radioimmunotherapy and helical tomotherapy. Through innovative laboratory and clinical research programs, we continue to investigate ways to further advance the efficacy and safety of radiation therapy.

Application Process

How to Apply
 
 
Application Checklist
 
  • ERAS application
  • Official college, graduate school and medical school transcripts
  • An official record of board scores (NBME, FLEX, USMLE, LMCC, COMLEX, VQE or FMGEMS).
  • A dean's letter and two other letters of recommendation.
  • A curriculum vita.
  • A personal statement.
 
 
Graduates from a medical school outside of the United States or Canada must submit a valid ECFMG certificate.

Applications for each academic year, which begins July 1, should be completed by December 1 of the previous calendar year. If you are selected for an interview, you will be invited to visit City of Hope for an interview with selected faculty. Interviews are conducted from late November through early February each year.
 
Contact
 
For further information, contact the program by phone or email:
 
Thalia Yaden
Residency Program Coordinator
City of Hope Department of Radiation Oncology
1500 E. Duarte Road, Duarte, CA 91010
Telephone: 626-301-8247, ext. 64163
radiationresident@coh.org
 

Faculty

In addition to caring for patients in their clinical practices, the City of Hope Department of Radiation Oncology faculty members are committed to teaching and facilitating the growth of medical knowledge.

Faculty members in the Department of Radiation Oncology include:
 
Radiation Oncologists:
 
  • Jeffrey Wong, M.D., FASTRO Chair
 
  • Eric Radany, M.D., Ph.D., Program Director
 
  • Richard Pezner, M.D.
 
  • Nayana Vora, M.D.
 
  • Yi-Jen Chen, M.D., Ph.D.
 
  • Khanh Nguyen, M.D.
 
  • Andrew Raubitschek, M.D. (Radioimmunotherapy)
 
 
 
Physicist:
 
  • Timothy Schultheiss, Ph.D. FACR, FAAPM, FASTRO, Director of Radiation Physics Cecil Staud, Ph.D.
 
  • An Liu, Ph.D.
 
  • Chun-Hui Han, Ph.D.
 
  • Sean Sun, M.S.
 
  • Lawrence Williams, Ph.D., FACR (Diagnostic Imaging)
 
  • James Bading, Ph.D. (Radioimmunotherapy)
 
 
 
Radiation Biology
 
  • Binghui Shen, Ph.D., Director, Radiation Biology
 
  • Jeremy Stark, Ph.D.
 
  • Fong-Fong Chu, Ph.D.
 

Facility and Department

City of Hope is recognized worldwide for its compassionate patient care, innovative science and translational research, which rapidly turns laboratory breakthroughs into promising new therapies. We are one of only 41 National Cancer Institute-designated Comprehensive Cancer Centers nationwide and a founding member of the National Comprehensive Cancer Network. 
 
On our park-like campus just northeast of Los Angeles, City of Hope Helford Clinical Research Hospital brings groundbreaking research and compassionate care under one roof. It embodies our mission to deliver the newest, most promising therapies to patients without delay, while creating an environment that encourages open collaboration between physicians, caregivers and clinical researchers.
 
City of Hope Department of Radiation Oncology treats more than 900 patients each year. The department is equipped with state-of-the art technology, with facility renovation underway.  The department offers the full spectrum of radiation therapy modalities, including:
 
  • External beam radiation therapy with high-energy photons and electrons.
  • 3-D Conformal Radiation Therapy
  • IMRT -- Intensity Modulated Radiation Therapy
  • IGRT -- Image Guided Radiation Therapy
  • Stereotactic Radiosurgery
  • Total Body and Total Marrow Irradiation in conjunction with a Bone Marrow Transplant
  • Brachytherapy with LDR and HDR techniques
  • Treatment with Unsealed Sources, including targeted radiopharmaceuticals and radio-immunotherapy
 
 

Therapy Equipment 
 
  • Two Helical TomoTherapy – IGRT units
  • One Varian 21EX dual energy (6 MeV and 10 MeV), MLC linear accelerators with multiple electron capability and IMRT
  • One 6 MeV Varian linear accelerators.
  • Varian high dose-rate afterloader for interstitial and intracavitary implants.
  • Variety of low dose-rate sources available for implantation.
  • Ultrasound guided equipment for permanent prostate seed implants. Equipment to be added soon
  • One Varian Trilogy dual energy with CBCT/OBI and SRS/SRT capable.
  • One Varian iX dual energy accelerator with CBCT/OBI
 
Planning / Verification Equipment
 
  • Large bore CT-Simulation unit, dedicated for treatment planning
  • One Varian conventional simulator
  • Varian Eclipse Treatment Planning System
  • TomoTherapy Treatment Planning System
  • IMPAC Radiation Oncology Management System
 
Planning Equipment to be added soon
 
  • GE multi slice PET/CT simulator dedicated to planning and response assessment
  • GE 1.5T MRI dedicated to radiation oncology planning and response assessment
 
Conferences
Residents will be required to attend various radiation oncology conferences each week, as well as multidisciplinary conferences. An integrated, multidisciplinary approach to patient management is stressed. 
 
Multidisciplinary clinics or tumor boards occur in breast cancer; GU/prostate cancer, sarcomas, head and neck cancers; pediatric cancers; gynecological malignancies; gastrointestinal cancers; central nervous system cancers; and lymphomas. There is frequent interaction between all specialties which care for these patients including medical oncology, pediatric oncology, general surgery, head and neck surgery, the bone marrow transplantation service, pain service, neurosurgery, gynecological oncologists, thoracic surgery, and other ancillary services. 
 
Residents are a vital and important part of this multidisciplinary approach to the treatment of patients with cancer.
 
Fellowships and Residencies
City of Hope offers a number of exciting fellowships and residencies in laboratory cancer and diabetes research, administration, clinical applications and other areas.

City of Hope is one of only 41 Comprehensive Cancer Centers in the country, the highest designation awarded by the National Cancer Institute to institutions that lead the way in cancer research, treatment, prevention and professional education.
Beckman Research Institute of City of Hope is internationally  recognized for its innovative biomedical research.
Students and professionals at City of Hope can access a plethora of medical databases, scientific journals, course materials, special collections, and other useful resources at our 12,000 square foot Lee Graff Library.
City of Hope has a long-standing commitment to Continuing Medical Education (CME), sharing advances in cancer research and treatment with the health-care community through CME courses such as conferences, symposia and other on and off campus CME opportunities for medical professionals.
Learn more about City of Hope's institutional distinctions, breakthrough innovations and collaborations.
NEWS & UPDATES
  • Cancer cells may be known for their uncontrollable growth and spread, but they also differ from normal tissue in another manner: how they produce energy. In healthy cells, energy is derived primarily from aerobic respiration, an oxygen-requiring process that extracts the maximum possible energy from glucose, or...
  • Clinical trials are expensive and complex, but they’re essential for bringing new therapies to patients. Edward Newman, Ph.D., associate professor of molecular pharmacology, just boosted City of Hope’s ability to conduct those studies with a five-year, $4.2 million grant from the National Cancer Institute...
  • Meet City of Hope’s new chair of the Department of Surgery – esteemed pancreatic and hepatobiliary surgeon, researcher and author Yuman Fong, M.D. As one of today’s most respected and recognizable physicians in the treatment of cancers of the liver, bile duct, gallbladder and pancreas, Fong has pioneered and en...
  • For most of her life, Southern California teenager Kayla Saikaly described herself as healthy, even very healthy. She played basketball. She never missed school with as much as a fever. Her worst childhood illness was nothing more than a cold. Then, when she was 13, her nose started bleeding after a basketball ...
  • Neuroblastoma is one of the deadliest childhood cancers, accounting for 15 percent of pediatric cancer deaths. For patients with high-risk neuroblastomas, the five-year survival rate is 40 to 50 percent even with the most rigorous treatments available today. But those odds may improve soon, thanks to a new comp...
  • For breast cancer survivors, a common worry is a recurrence of their cancer. Currently, these patients are screened with regular mammograms, but there’s no way to tell who is more likely to have a recurrence and who is fully cleared of her cancer. A new blood test – reported in Cancer Research, a journal of the...
  • Metastasis — the spreading of cancer cells from a primary tumor site to other parts of the body — generally leads to poorer outcomes for patients, so oncologists and researchers are constantly seeking new ways to detect and thwart this malicious process. Now City of Hope researchers may have identified a substa...
  • Deodorant, plastic bottles, grilled foods, artificial sweeteners, soy products … Do any of these products really cause cancer? With so many cancer myths and urban legends out there, why not ask the experts? They can debunk cancer myths while sharing cancer facts that matter, such as risk factors, preventi...
  • Cancer risk varies by ethnicity, as does the risk of cancer-related death. But the size of those differences can be surprising, highlighting the health disparities that exist among various ethnic groups in the United States. Both cancer incidence and death rates for men are highest among African-Americans, acco...
  • George Winston, known worldwide for his impressionistic, genre-defying music, considers music to be his first language, and admits he often stumbles over words – especially when he attempts languages other than English. There’s one German phrase he’s determined to perfect, however: danke schön. Winston thinks h...
  • Few decisions are more important than those involving health care, and few decisions can have such lasting impact, not only on oneself but on relatives and loved ones. Those choices, especially, should be made in advance – carefully, deliberately, free of pain and stress, and with much weighing of values and pr...
  • Using a card game to make decisions about health care, especially as those decisions relate to the end of life, would seem to be a poor idea. It isn’t. The GoWish Game makes those overwhelming, but all-important decisions not just easy, but natural. On each card of the 36-card deck is listed what seriously ill,...
  • Young adults and adolescents with cancer face unique challenges both during their treatment and afterward. Not only are therapies for children and older adults not always appropriate for them, they also must come to terms with the disease and treatment’s impact on their relationships, finances, school or ...
  • Breast cancer is the most common cancer, other than skin cancer, among women in the United States. It’s also the second-leading cause of cancer death, behind lung cancer. In the past several years, various task force recommendations and studies have questioned the benefits of broad screening guidelines fo...
  • Paternal age and the health effects it has on potential offspring have been the focus of many studies, but few have examined the effect parental age has on the risk of adult-onset hormone-related cancers (breast cancer, ovarian cancer and endometrial cancer). A team of City of Hope researchers, lead by Yani Lu,...